Codexis Archives - Executive Platforms: Thought Leader Series

Panel Discussion: Reflecting on the Past, Envisioning the Future: Shaping the New Landscape of Biomanufacturing

December 2, 2024

Assessing Changes in the CMC Ecosystem: Are We Overbuilding Capacity Again?
Uniting for Success: Strategies to Prevent Fragmentation and Foster Collaboration in Biomanufacturing
Pioneering New Ventures: Reasons to Establish a New Company Today and Anticipating Future Growth in the Business Ecosystem
Evaluating Production Platforms for Emerging Modalities: Which Platforms Will Best Serve the Future of Medicine?
Navigating the Future of Existing Platforms: Efficiently Addressing Market Needs for Established Therapies such as mAbs, ADCs, and mRNA-based Treatments

LIFE SCIENCES, VIDEO, LIFE SCIENCES

Welcome Day Panel: The Five Biggest Things Facing Our Shared Biomanufacturing Future

December 2, 2024

Discussing the most important new technologies in biomanufacturing today, with a special emphasis on what we want to do as our industry matures
Debating how talent and workforce development in our industry is changing, and what we should do about it
Listing the current factors affecting speed of development and efficient manufacturing. How do we continue to improve in a changing business landscape with special reference to IRA and the BIOSECURE Acts?
Understanding the current Regulatory environment with an eye for how things are going to evolve into the future
How can we improve the access of biologic medicines?

LIFE SCIENCES, VIDEO, LIFE SCIENCES

Welcome Day Panel: The Evolution of Innovative Modalities —Defining the Future of Manufacturing & Development

December 2, 2024

Science outpacing Industrialization of Technology: Reviewing next generation cell and gene therapy platforms/technologies, gene editing technologies to unlock new possibilities.
Manufacturing to Scale: Scaling up to meet demand, comparability challenges, production capacity, AI tools and AAV production will drive speed to market/approval
Regulatory Evolution: evolving regulatory frameworks and innovative products necessitate industry and local and global regulatory collaboration to define efficient pathways to approval
Economic/Global Expansion: expanding access to ATMP’s in new regions, reducing cost of goods via production efficiency, expanding global infrastructure to facilitate access to new patients

LIFE SCIENCES, VIDEO, LIFE SCIENCES

Revolutionizing RNAi Therapeutics Manufacturing with Enzymes

December 2, 2024

Stefan Lutz joined Codexis in 2020 as Senior Vice President of Research to lead the company’s research team advancing the discovery of proteins. Previously, he was a Professor and Chair of the Chemistry Department at Emory University, joining the university in 2002 and ascending to Department Chair in 2014. Stefan has co-authored over 65 peer-reviewed articles and six technical books and journals, holds six patents and is a frequent industry speaker. Dr. Lutz received a B.Sc. in chemistry/chemical engineering from Zurich University of Applied Sciences, an M.Sc. in Biotechnology from the University of Teesside and a Ph.D. in chemistry from the University of Florida.

Codexis

Panel Discussion: Reflecting on the Past, Envisioning the Future: Shaping the New Landscape of Biomanufacturing

Welcome Day Panel: The Five Biggest Things Facing Our Shared Biomanufacturing Future

Welcome Day Panel: The Evolution of Innovative Modalities —Defining the Future of Manufacturing & Development

Revolutionizing RNAi Therapeutics Manufacturing with Enzymes

NASCES

NAFS

NAFMS

EUSCES

BMWS

NALES

MDMES

NAFES

NASRS

NAHRES

NAMES

PMWS

NAISS

Categories

Newsletter